SEC Filings for Cleveland BioLabs Inc. (CBLI)

$ 1.75   -0.03 (-1.69%) Volume: 62.68k 12:02 PM EDT Jun 3, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
424B5Prospectus [Rule 424(b)(5)]1506/02/2020
424B3Prospectus [Rule 424(b)(3)]1505/29/2020
S-3Registration statement under Securities Act of 19332305/21/2020
8-KCurrent report pursuant to Section 13 or 15(d)805/15/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)2405/15/2020
8-KCurrent report pursuant to Section 13 or 15(d)305/04/2020
10-K/A[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]1704/29/2020
10-KAnnual report pursuant to Section 13 or 15(d)8104/15/2020
NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405303/31/2020
8-KCurrent report pursuant to Section 13 or 15(d)302/24/2020
SC 13GStatement of acquisition of beneficial ownership by individuals101/24/2020
3Initial statement of beneficial ownership of securities112/23/2019
8-KCurrent report pursuant to Section 13 or 15(d)112/18/2019
8-KCurrent report pursuant to Section 13 or 15(d)112/03/2019
<<
First
<
Prev
123456789101112131415